RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Lifecore Biomedical ROE 2024

Lifecore Biomedical ROE

-2.84

Lifecore Biomedical Dividend yield

Ticker

LFCR

ISIN

US5147661046

WKN

899376

In 2024, Lifecore Biomedical's return on equity (ROE) was -2.84, a 124.38% increase from the -1.26 ROE in the previous year.

Lifecore Biomedical Aktienanalyse

What does Lifecore Biomedical do?

Landec Corp is a US-American company specialized in the development, manufacturing, and marketing of innovative products in the Agribusiness and Biotechnology sectors. It was founded in 1986 as a spin-off from the engineering faculty of Stanford University. The company follows a unique business model based on the integration of advanced technologies and biological processes. This aims to achieve sustainable agriculture that is both mindful of natural resources and achieves high yields. One of Landec's main divisions is the Fresh-Cut Products segment, where the company produces a variety of high-quality salads, vegetable, and fruit snacks that are distributed under the brand Eat Smart®. These products are known for their freshness, taste, and healthy nutritional values, and have gained high recognition in the USA. Another important business division of Landec is the Apio Packaging segment, specialized in the manufacturing and marketing of innovative packaging solutions for fresh fruits and vegetables. The packaging, distributed under the brand BreatheWay®, is equipped with a unique technology that regulates gas exchange within the package and extends the shelf life of the contents. In addition to these core segments, Landec is also active in the field of Biotechnology. Here, the company develops innovative products and technologies for use in human healthcare as well as the agricultural industry. An example of this is Apio's recently introduced whole plant juice called GreenWise™. Landec Corp is known for its innovation capabilities and its ability to develop new products and technologies. Throughout its history, the company has acquired a number of patents and awards and constantly strives to improve and advance its products. Overall, Landec Corp is a company that focuses on sustainability, innovation, and quality. With its unique business model and wide range of products and services, the company is well-positioned to continue growing and expanding its leadership position in the agriculture and biotechnology industry. Lifecore Biomedical ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Lifecore Biomedical's Return on Equity (ROE)

Lifecore Biomedical's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Lifecore Biomedical's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Lifecore Biomedical's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Lifecore Biomedical’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Lifecore Biomedical Stock

What is the ROE (Return on Equity) of Lifecore Biomedical this year?

The ROE of Lifecore Biomedical this year is -2.84 undefined.

How has the Return on Equity (ROE) of Lifecore Biomedical developed compared to the previous year?

The ROE of Lifecore Biomedical has increased by 124.38% increased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Lifecore Biomedical?

A high ROE indicates that Lifecore Biomedical generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Lifecore Biomedical?

A low ROE can indicate that Lifecore Biomedical is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Lifecore Biomedical affect the company?

A change in ROE (Return on Equity) of Lifecore Biomedical can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Lifecore Biomedical?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Lifecore Biomedical?

Some factors that can influence Lifecore Biomedical's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Lifecore Biomedical pay?

Over the past 12 months, Lifecore Biomedical paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Lifecore Biomedical is expected to pay a dividend of 0 USD.

What is the dividend yield of Lifecore Biomedical?

The current dividend yield of Lifecore Biomedical is .

When does Lifecore Biomedical pay dividends?

Lifecore Biomedical pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Lifecore Biomedical?

Lifecore Biomedical paid dividends every year for the past 0 years.

What is the dividend of Lifecore Biomedical?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Lifecore Biomedical located?

Lifecore Biomedical is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von Lifecore Biomedical kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Lifecore Biomedical from 6/2/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/2/2024.

When did Lifecore Biomedical pay the last dividend?

The last dividend was paid out on 6/2/2024.

What was the dividend of Lifecore Biomedical in the year 2023?

In the year 2023, Lifecore Biomedical distributed 0 USD as dividends.

In which currency does Lifecore Biomedical pay out the dividend?

The dividends of Lifecore Biomedical are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Lifecore Biomedical

Our stock analysis for Lifecore Biomedical Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Lifecore Biomedical Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.